Mitoxantrone and Injury - a phase IV clinical study of FDA data

Summary:

Injury is reported as a side effect among people who take Mitoxantrone (mitoxantrone hydrochloride), especially for people who are female, 50-59 old, also take Zometa, and have Ovarian cancer.

The phase IV clinical study analyzes which people have Injury when taking Mitoxantrone. It is created by eHealthMe based on reports of 8,117 people who have side effects when taking Mitoxantrone from the FDA, and is updated regularly.

What is Mitoxantrone?

Mitoxantrone has active ingredients of mitoxantrone hydrochloride. eHealthMe is studying from 8,125 Mitoxantrone users. Check the latest studies of Mitoxantrone.

What is Injury?

Injury is found to be associated with 2,165 drugs and 2,231 conditions by eHealthMe. Check the latest studies of Injury.

On Jul, 19, 2026

8,117 people reported to have side effects when taking Mitoxantrone.
Among them, 52 people (0.64%) have Injury.

Among these 52 people:

What is the gender of people who have Injury when taking Mitoxantrone? *

female: 51.02 %
male: 48.98 %

What is the age of people who have Injury when taking Mitoxantrone? *

What are other drugs people take besides Mitoxantrone? *

What are other side effects people have besides Injury? *

Pain In Jaw: 44 people, 84.62%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 37 people, 71.15%
Bone Disorder: 35 people, 67.31%
Anaemia (lack of blood): 35 people, 67.31%
Osteonecrosis Of Jaw (death of bone of jaw): 33 people, 63.46%
Spinal Osteoarthritis (joint cartilage loss in spine): 33 people, 63.46%
Oedema Peripheral (superficial swelling): 32 people, 61.54%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 31 people, 59.62%
Dyspnea (difficult or laboured breathing): 29 people, 55.77%
Purulent Discharge (discharge that contains pus): 29 people, 55.77%

What are the existing conditions these people have? *

Migraine (headache): 23 people, 44.23%
Neoplasm Malignant (cancer tumour): 23 people, 44.23%
Discomfort: 23 people, 44.23%
Hot Flush (sudden feelings of heat): 23 people, 44.23%
Breast Cancer Metastatic: 23 people, 44.23%
Breast Cancer: 23 people, 44.23%
Ovarian Cancer (cancer of ovary): 23 people, 44.23%
Granulocyte Count Decreased: 22 people, 42.31%
Prostate Cancer Metastatic: 8 people, 15.38%
Pain: 7 people, 13.46%

* Approximation only. Some reports may have incomplete information.

Do you take Mitoxantrone and have Injury?

- Check whether Injury is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mitoxantrone:

Mitoxantrone (8,125 reports)

Injury treatments and more:

Injury (120,051 reports)

Browse all side effects of Mitoxantrone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injury:

Injury (2,165 drugs)

Browse all the conditions that are associated with Injury:

Injury (2,231 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mitoxantrone hydrochloride (the active ingredients of Mitoxantrone) and Mitoxantrone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.